Vyndaqel Market Size, Growth, Global Trends, Forecast 2034

Vyndaqel Market

Vyndaqel Market By Disease Type (Familial Amyloid Polyneuropathy [FAP], Wild-type or Hereditary Transthyretin-mediated Amyloidosis Cardiomyopathy [ATTR-CM]), Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Pharmaceutical Report Format : PDF Pages: 216 Report Code: ZMR-10030 Published Date: Nov-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 2.01 Billion USD 6.50 Billion 15.80% 2024

Vyndaqel Market

Request Free Sample

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Vyndaqel Market, (2025 - 2034) (USD Billion )
    • 2.2 Global Vyndaqel Market : snapshot
  • Chapter 3. Global Vyndaqel Market - Industry Analysis
    • 3.1 Vyndaqel Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The Vyndaqel market fueled by the aging population and increased incidence of heart failure
    • 3.3 Market Restraints
      • 3.3.1. Competition from alternative therapies and generics negatively impacts market progress
    • 3.4 Market Opportunities
      • 3.4.1. Increasing diagnosis through advanced screening tools create promising avenues for the Vyndaqel industry growth
    • 3.5 Market Challenges
      • 3.5.1. Limited awareness and misdiagnosis restrict the market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Disease Type
      • 3.7.2 Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Vyndaqel Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Vyndaqel Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Vyndaqel Market - Disease Type Analysis
    • 5.1 Global Vyndaqel Market overview: By Disease Type
      • 5.1.1 Global Vyndaqel Market share, By Disease Type, 2024 and 2034
    • 5.2 Familial Amyloid Polyneuropathy (FAP)
      • 5.2.1 Global Vyndaqel Market by Familial Amyloid Polyneuropathy (FAP), 2025 - 2034 (USD Billion )
    • 5.3 Wild-type or Hereditary Transthyretin-mediated Amyloidosis Cardiomyopathy (ATTR-CM)
      • 5.3.1 Global Vyndaqel Market by Wild-type or Hereditary Transthyretin-mediated Amyloidosis Cardiomyopathy (ATTR-CM), 2025 - 2034 (USD Billion )
  • Chapter 6. Global Vyndaqel Market - Distribution Channel Analysis
    • 6.1 Global Vyndaqel Market overview: By Distribution Channel
      • 6.1.1 Global Vyndaqel Market share, By Distribution Channel, 2024 and 2034
    • 6.2 Hospital Pharmacies
      • 6.2.1 Global Vyndaqel Market by Hospital Pharmacies, 2025 - 2034 (USD Billion )
    • 6.3 Specialty Pharmacies
      • 6.3.1 Global Vyndaqel Market by Specialty Pharmacies, 2025 - 2034 (USD Billion )
    • 6.4 Retail Pharmacies
      • 6.4.1 Global Vyndaqel Market by Retail Pharmacies, 2025 - 2034 (USD Billion )
  • Chapter 7. Vyndaqel Market - Regional Analysis
    • 7.1 Global Vyndaqel Market Regional Overview
    • 7.2 Global Vyndaqel Market Share, by Region, 2024 & 2034 (USD Billion )
    • 7.3. North America
      • 7.3.1 North America Vyndaqel Market, 2025 - 2034 (USD Billion )
        • 7.3.1.1 North America Vyndaqel Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 North America Vyndaqel Market, by Disease Type, 2025 - 2034
      • 7.4.1 North America Vyndaqel Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5 North America Vyndaqel Market, by Distribution Channel, 2025 - 2034
      • 7.5.1 North America Vyndaqel Market, by Distribution Channel, 2025 - 2034 (USD Billion )
    • 7.4. Europe
      • 7.4.2 Europe Vyndaqel Market, 2025 - 2034 (USD Billion )
        • 7.4.2.1 Europe Vyndaqel Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Europe Vyndaqel Market, by Disease Type, 2025 - 2034
      • 7.4.1 Europe Vyndaqel Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5 Europe Vyndaqel Market, by Distribution Channel, 2025 - 2034
      • 7.5.1 Europe Vyndaqel Market, by Distribution Channel, 2025 - 2034 (USD Billion )
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Vyndaqel Market, 2025 - 2034 (USD Billion )
        • 7.5.3.1 Asia Pacific Vyndaqel Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Asia Pacific Vyndaqel Market, by Disease Type, 2025 - 2034
      • 7.4.1 Asia Pacific Vyndaqel Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5 Asia Pacific Vyndaqel Market, by Distribution Channel, 2025 - 2034
      • 7.5.1 Asia Pacific Vyndaqel Market, by Distribution Channel, 2025 - 2034 (USD Billion )
    • 7.6. Latin America
      • 7.6.4 Latin America Vyndaqel Market, 2025 - 2034 (USD Billion )
        • 7.6.4.1 Latin America Vyndaqel Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 Latin America Vyndaqel Market, by Disease Type, 2025 - 2034
      • 7.4.1 Latin America Vyndaqel Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5 Latin America Vyndaqel Market, by Distribution Channel, 2025 - 2034
      • 7.5.1 Latin America Vyndaqel Market, by Distribution Channel, 2025 - 2034 (USD Billion )
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Vyndaqel Market, 2025 - 2034 (USD Billion )
        • 7.7.5.1 The Middle-East and Africa Vyndaqel Market, by Country, 2025 - 2034 (USD Billion )
    • 7.4 The Middle-East and Africa Vyndaqel Market, by Disease Type, 2025 - 2034
      • 7.4.1 The Middle-East and Africa Vyndaqel Market, by Disease Type, 2025 - 2034 (USD Billion )
    • 7.5 The Middle-East and Africa Vyndaqel Market, by Distribution Channel, 2025 - 2034
      • 7.5.1 The Middle-East and Africa Vyndaqel Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • Chapter 8. Company Profiles
    • 8.1 Pfizer Inc., Alnylam Pharmaceuticals, Ionis Pharmaceuticals, BridgeBio Pharma (Eidos Therapeutics), AstraZeneca, Takeda Pharmaceutical, GlaxoSmithKline (GSK), Novo Nordisk, Sanofi, Bristol Myers Squibb (BMS), Amgen, Biogen, Johnson & Johnson (Janssen), Roche, Bayer AG, and others.
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Vyndaqel Market, 2025 - 2034 (USD Billion )
  • 4. Porter’s Five Forces Analysis
  • 5. Global Vyndaqel Market attractiveness, By Disease Type
  • 6. Global Vyndaqel Market attractiveness, By Distribution Channel
  • 7. Global Vyndaqel Market share by Disease Type, 2025 and 2034 (USD Billion )
  • 8. Global Vyndaqel Market by Familial Amyloid Polyneuropathy (FAP), 2025 - 2034 (USD Billion )
  • 9. Global Vyndaqel Market by Wild-type or Hereditary Transthyretin-mediated Amyloidosis Cardiomyopathy (ATTR-CM), 2025 - 2034 (USD Billion )
  • 10. Global Vyndaqel Market share by Distribution Channel, 2025 and 2034 (USD Billion )
  • 11. Global Vyndaqel Market by Hospital Pharmacies, 2025 - 2034 (USD Billion )
  • 12. Global Vyndaqel Market by Specialty Pharmacies, 2025 - 2034 (USD Billion )
  • 13. Global Vyndaqel Market by Retail Pharmacies, 2025 - 2034 (USD Billion )
  • 14. Global Vyndaqel Market share, by Region, 2025 and 2034
  • 15. North America Vyndaqel Market, 2025 - 2034 (USD Billion )
  • 16. Europe Vyndaqel Market, 2025 - 2034 (USD Billion )
  • 17. Asia Pacific Vyndaqel Market, 2025 - 2034 (USD Billion )
  • 18. Latin America Vyndaqel Market, 2025 - 2034 (USD Billion )
  • 19. The Middle-East and Africa Vyndaqel Market, 2025 - 2034 (USD Billion )

Table Of Tables

  • 1. Global Vyndaqel Market: Snapshot
  • 2. Drivers of the Vyndaqel Market: impact analysis
  • 3. North America Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 4. North America Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 5. U.S. Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 6. U.S. Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 7. Canada Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 8. Canada Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 9. Europe Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 10. Europe Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 11. Germany Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 12. Germany Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 13. France Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 14. France Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 15. U.K. Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 16. U.K. Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 17. Italy Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 18. Italy Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 19. Spain Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 20. Spain Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 21. Rest of Europe Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 22. Rest of Europe Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 23. Asia Pacific Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 24. Asia Pacific Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 25. China Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 26. China Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 27. Japan Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 28. Japan Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 29. India Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 30. India Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 31. South Korea Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 32. South Korea Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 33. South-East Asia Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 34. South-East Asia Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 35. Rest of Asia Pacific Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 36. Rest of Asia Pacific Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 37. Latin America Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 38. Latin America Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 39. Brazil Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 40. Brazil Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 41. Mexico Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 42. Mexico Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 43. Rest of Latin America Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 44. Rest of Latin America Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 45. The Middle-East and Africa Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 46. The Middle-East and Africa Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 47. GCC Countries Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 48. GCC Countries Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 49. South Africa Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 50. South Africa Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
  • 51. Rest of Middle-East Africa Vyndaqel Market revenue, By Disease Type, 2025 - 2034 (USD Billion )
  • 52. Rest of Middle-East Africa Vyndaqel Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )

Methodology

FrequentlyAsked Questions

Vyndaqel (tafamidis) is a medicinal drug that treats transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive and rare disease in which abnormal protein deposits build up in the heart, resulting in failure. It works by stabilizing the transthyretin protein, slowing the creation of amyloid deposits, and helping preserve cardiac function.

The global Vyndaqel market is projected to grow due to the rising prevalence of transthyretin amyloidosis (ATTR), expanding healthcare expenditure globally, and robust clinical evidence supporting Vyndaqel efficacy.

According to study, the global Vyndaqel market size was worth around USD 2.01 billion in 2024 and is predicted to grow to around USD 6.50 billion by 2034.

The CAGR value of the Vyndaqel market is expected to be around 15.80% during 2025-2034.

Market trends and consumer preferences are evolving toward personalized therapy, earlier diagnosis, and enhanced access to high-cost orphan drugs like Vyndaqel.

North America is expected to lead the global Vyndaqel market during the forecast period.

The U.S. leads the Vyndaqel market due to early FDA approval, high ATTR-CM prevalence, broad insurance coverage, and strong healthcare infrastructure.

The key players profiled in the global Vyndaqel market include Pfizer Inc., Alnylam Pharmaceuticals, Ionis Pharmaceuticals, BridgeBio Pharma (Eidos Therapeutics), AstraZeneca, Takeda Pharmaceutical, GlaxoSmithKline (GSK), Novo Nordisk, Sanofi, Bristol Myers Squibb (BMS), Amgen, Biogen, Johnson & Johnson (Janssen), Roche, and Bayer AG.

Stakeholders should focus on geographic expansion, early diagnosis programs, real-world evidence generation, and patient support services to stay competitive in the Vyndaqel market.

The report examines key aspects of the Vyndaqel market, including a detailed analysis of existing growth factors and restraints, as well as an examination of future growth opportunities and challenges that will impact the market.

  • zion payment modes

List of Contents

VyndaqelIndustry Perspective:Key Insights:OverviewMarket DynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisKey Market TrendsThe global market is segmented as follows:

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed